(XENE) Xenon Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xenon Pharmaceuticals | (XENE) share price targets
Complete technical analysis of Xenon Pharmaceuticals (XENE) by charts plus indicators, forecast predictions and share price targets for Xenon Pharmaceuticals (XENE)
Xenon Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Xenon Pharmaceuticals is 2246720
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Wed Jul 2025 | 32.68 | 31.68 | 33.51 | 31.65 | 0.56 times |
| 08 Tue Jul 2025 | 31.42 | 31.83 | 32.24 | 31.22 | 0.389 times |
| 07 Mon Jul 2025 | 31.83 | 32.69 | 33.12 | 31.64 | 0.317 times |
| 03 Thu Jul 2025 | 33.26 | 33.70 | 33.83 | 33.06 | 0.219 times |
| 02 Wed Jul 2025 | 33.37 | 31.97 | 33.44 | 31.90 | 0.57 times |
| 01 Tue Jul 2025 | 32.09 | 31.16 | 32.53 | 31.09 | 0.711 times |
| 30 Mon Jun 2025 | 31.30 | 32.32 | 32.57 | 31.16 | 0.477 times |
| 27 Fri Jun 2025 | 32.40 | 32.35 | 32.99 | 32.00 | 5.854 times |
| 26 Thu Jun 2025 | 32.20 | 31.72 | 32.23 | 31.34 | 0.454 times |
| 25 Wed Jun 2025 | 31.76 | 32.08 | 32.37 | 31.54 | 0.642 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 32.7 as stoploss in an intra day sell trade for a target of 32.15. However, stock will show a bullish move above 32.7.
Share price targets for Xenon Pharmaceuticals (XENE)
| Target Type | Value |
| Downside Target | 26.74 |
| Downside Target | 28.19 |
| Downside Target | 28.97 |
| Downside Target | 30.77 |
| Upside Target | 32.70 |
| Upside Target | 33.46 |
| Upside Target | 33.51 |
| Upside Target | 33.83 |
| Upside Target | 38.08 |
| Upside Target | 38.63 |
| Upside Target | 39.01 |
Intraday share price targets for Xenon Pharmaceuticals (XENE)
| Target Type | Value |
| Downside Intraday Target | 31.43 |
| Downside Intraday Target | 30.18 |
| Upside Intraday Target | 33.72 |
| Upside Intraday Target | 34.76 |
| Downside Intraday Target | 32.47 |
Weekly technical analysis of Xenon Pharmaceuticals (XENE)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Wed Jul 2025 | 32.68 | 32.69 | 33.51 | 31.22 | 0.641 times |
| 03 Thu Jul 2025 | 33.26 | 32.32 | 33.83 | 31.09 | 0.257 times |
| 27 Fri Jun 2025 | 32.40 | 31.60 | 32.99 | 31.11 | 8.155 times |
| 20 Fri Jun 2025 | 32.05 | 31.92 | 32.72 | 31.22 | 0.536 times |
| 13 Fri Jun 2025 | 32.76 | 32.00 | 33.46 | 30.77 | 1.013 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xenon Pharmaceuticals (XENE)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Wed Jul 2025 | 32.68 | 31.16 | 33.83 | 31.09 | 0.22 times |
| 30 Mon Jun 2025 | 31.30 | 29.11 | 33.46 | 28.97 | 0.922 times |
| 30 Fri May 2025 | 28.85 | 38.20 | 39.01 | 28.19 | 1.649 times |
| 30 Wed Apr 2025 | 38.20 | 33.57 | 38.63 | 26.74 | 2.164 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xenon Pharmaceuticals (XENE)
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xenon Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Xenon Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xenon Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xenon Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xenon Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 32.31 and Xenon Pharmaceuticals (XENE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xenon Pharmaceuticals (XENE) stock. Volume based technical analysis of Xenon Pharmaceuticals (XENE) stock is negative.
Xenon Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Xenon Pharmaceuticals ( (XENE) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xenon Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Xenon Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xenon Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xenon Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xenon Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 32.31 and Xenon Pharmaceuticals (XENE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xenon Pharmaceuticals (XENE) stock. Volume based technical analysis of Xenon Pharmaceuticals (XENE) stock is negative.
Xenon Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.